The Campbell's Company (CPB)
Exploring Analyst Estimates for Campbell (CPB) Q3 Earnings, Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Campbell (CPB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended April 2026.
Earnings Preview: Campbell's (CPB) Q3 Earnings Expected to Decline
Campbell (CPB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Bottom Fishing Club: Campbell's 7.7x EV/EBITDA Is More Than Interesting
Campbell's Company trades near industry-low EV/EBITDA multiples, making it an attractive takeover target. GLP-1 medicine-driven declines in processed food sales and high debt have pressured CPB's profits and share price since 2022. CPB's 7.7x trailing and 8x forward EV/EBITDA ratios are compelling, especially if a recession or bear market emerges in 2026.
Campbell's Faces Challenges Ahead, But It Is Actively Adapting
The Campbell's Company trades near all-time lows, reflecting persistent industry-wide headwinds and ongoing fundamental deterioration in sales and profits. CPB maintains a forward P/E of 9 and a dividend yield of 7.75%, offering value if even modest operational improvements materialize. Input cost inflation, particularly from transport and soft commodities, poses near-term profit risks as CPB struggles to pass costs to consumers.
The Campbell's Company: Distressed State And Debt Level Can Serve As A Catalyst
The Campbell's Company's distressed state, driven by competitive and secular headwinds, and elevated debt level may serve as a catalyst that will unlock the company's value. Campbell's predicaments will coerce the company to take actions such as divestitures, resulting in greater strategic focus and conservative capital structure, imperative in today's CPG market. With an earnings yield of roughly 10.5%, Campbell's current valuation offers good value when compared to alternatives available to investors.
Why Is Campbell (CPB) Down 4% Since Last Earnings Report?
Campbell (CPB) reported earnings 30 days ago. What's next for the stock?
Campbell's Soup stock left simmering near 23-year low
Things went downhill for Campbell's (NASDAQ: CPB) in November 2025, when the then-vice president and chief information security officer, Martin Bally, was caught on tape mocking “poor people,” calling the company's own products “3D-printed meat,” and making racist comments about his co-workers.
The Campbell's Company: Resist The Temptation To Buy For Now
The Campbell's Company is at multi-decade lows. They offer a 7% dividend yield, and the forward P/E is at 10, but the company faces significant near-term headwinds. Sales are declining, margins are contracting, and FY2026 guidance was lowered, reflecting ongoing macro environment challenges. Despite the weakness, Campbell's cost control and new product launches targeting cook-at-home trends offer some upside potential.
Financial Review: Campbell’s (NASDAQ:CPB) versus US Foods (NYSE:USFD)
Campbell's (NASDAQ: CPB - Get Free Report) and US Foods (NYSE: USFD - Get Free Report) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Insider and Institutional Ownership 52.4% of Campbell's shares
Campbell's Is Dangerously Close to Getting Kicked Out of the S&P 500. Here's Why the High-Yield Dividend Stock Is a Buy Anyway.
Campbell's is at multi-year lows, making it one of the smallest S&P 500 components. Management slashed guidance, anticipating negative sales and a 23% to 26% decrease in adjusted earnings per share.
Campbell's posts one of worst quarters in years: revenues fell 5%, organic sales dropped 3%
One market analyst put it bluntly on air this week: “Yesterday, Campbell's reported one of the worst quarters I've seen in ages.
Campbell's Q2 Earnings & Revenues Miss Estimates, Sales Down 5% Y/Y
CPB misses Q2 estimates as EPS drops 31% and sales fall 5% year over year, hurt by weak snacks demand and cost inflation.
